Skip to main content
GINWA ENTERPRISE (GROUP) INC. logo

GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings

Ticker · 600080 ISIN · CNE000000QQ8 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,715 across all filing types
Latest filing 2026-05-20 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 600080

About GINWA ENTERPRISE (GROUP) INC.

http://www.ginwa.com.cn/

Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.

Recent filings

Filing Released Lang Actions
金花企业（集团）股份有限公司关于集中竞价减持已回购股份结果公告
Transaction in Own Shares Classification · 92% confidence The document is an official announcement detailing the implementation results of the company’s concentrated bidding sale of previously repurchased shares, including quantities, timeframes, prices, and compliance confirmations. This clearly corresponds to a report of transactions in the company’s own shares (share repurchases and disposals), which matches the “Transaction in Own Shares” category.
2026-05-20 Chinese
陕西博硕律师事务所关于金花企业（集团）股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 30% confidence The document is a legal opinion letter (“法律意见书”) issued by an external law firm regarding the legality of the 2025 Annual General Meeting (AGM) of Jinhua Enterprises (Group) Co., Ltd. It extensively reviews the AGM’s convening procedures, attendance, and voting process and provides detailed voting results. This is not a presentation or investor slide deck (AGM-R), nor a proxy solicitation document (PSI). Although it contains vote counts, it is fundamentally a legal opinion rather than a straightforward vote-results announcement (DVA). There is no dedicated category for legal opinion letters, so under the taxonomy, this falls into the miscellaneous regulatory filing category. Hence, it should be classified as a general Regulatory Filing (RNS).
2026-05-20 Chinese
金花企业（集团）股份有限公司第十一届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a Chinese board resolution announcement (‘董事会会议决议公告’) detailing the election of the chairman, vice chairman, committee members, and appointments of senior management and board secretary. It clearly relates to changes in the company’s board of directors and senior management, fitting the Board/Management Information category.
2026-05-20 Chinese
金花企业（集团）股份有限公司关于选举职工代表董事的公告
Board/Management Information Classification · 92% confidence The document is a corporate announcement regarding the election of an employee‐representative director to the company’s board, detailing the nominees, term, and compliance with legal requirements. It does not contain financial results, investor presentation material, or a formal report; it is purely a board/management information update. Therefore, it fits the Board/Management Information category (MANG).
2026-05-20 Chinese
金花企业（集团）股份有限公司2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of resolutions passed at the company’s 2025 Annual General Meeting, including vote counts and percentages for each proposal and election results. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements (DVA)” for shareholder vote outcomes at an AGM.
2026-05-20 Chinese
金花企业（集团）股份有限公司关于参加“2026年陕西辖区上市公司投资者集体接待日暨2025年度业绩说明会”的公告
Regulatory Filings Classification · 75% confidence The document is an announcement (in Chinese) regarding the company’s participation in a collective investor reception day and the 2025 annual performance explanation meeting. It provides logistical details (date, platform, participants) for an upcoming investor event, rather than containing substantive financial statements, investor presentation slides, or the actual annual report. It is not a report itself but a regulatory notice announcing an event. There is no direct publication of a report or attachments included, so it does not qualify as RPA. Therefore, it falls into the general regulatory announcement category (RNS).
2026-05-12 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.